Fennec Pharmaceuticals Inc.
FENC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001211583
In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Fennec Pharmaceuticals Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 30 | 28 | −2 |
| Shares | 11.3M | 11.4M | +90.4K (+0.8%) |
| Value | $49.9M | $64.1M | +$14.1M (+28.3%) |
New holders (1)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FMR LLC | 112 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Fennec Pharmaceuticals Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Citadel Advisors LLC | 14,874 | $65.0K |
| Simplex Trading, LLC | 899 | $3.00K |
| TD Waterhouse Canada Inc. | 555 | $2.50K |